Literature DB >> 11708907

Synthesis, nicotinic acetylcholine receptor binding, and antinociceptive properties of 2-exo-2-(2'-substituted-3'-phenyl-5'-pyridinyl)-7-azabicyclo[2.2.1]heptanes. Novel nicotinic antagonist.

F I Carroll1, J R Lee, H A Navarro, L E Brieaddy, P Abraham, M I Damaj, B R Martin.   

Abstract

A series of 2'-substituted-3'-phenyl epibatidine analogues were synthesized and evaluated for inhibition of binding at nicotine acetylcholine receptors and for antinociceptive properties in mice. The introduction of a bulky phenyl group at the 3'-position exerted a profound influence on both receptor binding and antinociceptive effects. Substitution of different groups at the 2'-position distinguished between agonist and antagonist properties. These results demonstrate that structural requirements for receptor activities and recognition are distinctively different.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11708907     DOI: 10.1021/jm015561v

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  11 in total

1.  Synthesis, nicotinic acetylcholine receptor binding, and pharmacological properties of 3'-(substituted phenyl)deschloroepibatidine analogs.

Authors:  F Ivy Carroll; Yasuno Yokota; Wei Ma; Jeffrey R Lee; Lawrence E Brieaddy; Jason P Burgess; Hernán A Navarro; M I Damaj; Billy R Martin
Journal:  Bioorg Med Chem       Date:  2007-10-13       Impact factor: 3.641

2.  Synthesis and nicotinic acetylcholine receptor in vitro and in vivo pharmacological properties of 2'-fluoro-3'-(substituted phenyl)deschloroepibatidine analogues of 2'-fluoro-3'-(4-nitrophenyl)deschloroepibatidine.

Authors:  Pauline Ondachi; Ana Castro; Charles W Luetje; M Imad Damaj; S Wayne Mascarella; Hernán A Navarro; F Ivy Carroll
Journal:  J Med Chem       Date:  2012-07-11       Impact factor: 7.446

3.  Highly Selective and Potent α4β2 nAChR Antagonist Inhibits Nicotine Self-Administration and Reinstatement in Rats.

Authors:  Jinhua Wu; Andrea Cippitelli; Yaohong Zhang; Ginamarie Debevec; Jennifer Schoch; Akihiko Ozawa; Yongping Yu; Huan Liu; Wenteng Chen; Richard A Houghten; Gregory S Welmaker; Marc A Giulianotti; Lawrence Toll
Journal:  J Med Chem       Date:  2017-12-13       Impact factor: 7.446

4.  Design, synthesis, and biological activity of 5'-phenyl-1,2,5,6-tetrahydro-3,3'-bipyridine analogues as potential antagonists of nicotinic acetylcholine receptors.

Authors:  Yafei Jin; Xiaoqin Huang; Roger L Papke; Emily M Jutkiewicz; Hollis D Showalter; Chang-Guo Zhan
Journal:  Bioorg Med Chem Lett       Date:  2017-08-14       Impact factor: 2.823

5.  EPIBATIDINE ANALOGS SYNTHESIZED FOR CHARACTERIZATION OF NICOTINIC PHARMACOPHORES-A REVIEW.

Authors:  F Ivy Carroll
Journal:  Heterocycles       Date:  2009       Impact factor: 0.831

Review 6.  Nicotinic agonists, antagonists, and modulators from natural sources.

Authors:  John W Daly
Journal:  Cell Mol Neurobiol       Date:  2005-06       Impact factor: 5.046

7.  Synthesis, nicotinic acetylcholine receptor binding, in vitro and in vivo pharmacology properties of 3'-(substituted pyridinyl)-deschloroepibatidine analogs.

Authors:  Pauline W Ondachi; Zhuo Ye; Ana H Castro; Charles W Luetje; M Imad Damaj; S Wayne Mascarella; Hernán A Navarro; F Ivy Carroll
Journal:  Bioorg Med Chem       Date:  2015-07-17       Impact factor: 3.641

Review 8.  Epibatidine: impact on nicotinic receptor research.

Authors:  Małgorzata Dukat; Richard A Glennon
Journal:  Cell Mol Neurobiol       Date:  2003-06       Impact factor: 5.046

9.  3'-Fluoro substitution in the pyridine ring of epibatidine improves selectivity and efficacy for alpha4beta2 versus alpha3beta4 nAChRs.

Authors:  Galya R Abdrakhmanova; F Ivy Carroll; M I Damaj; Billy R Martin
Journal:  Neuropharmacology       Date:  2008-08-15       Impact factor: 5.250

10.  Synthesis, nicotinic acetylcholine receptor binding, and antinociceptive properties of 3'-(substituted phenyl)epibatidine analogues. Nicotinic partial agonists.

Authors:  F Ivy Carroll; Wei Ma; Liu Deng; Hernán A Navarro; M Imad Damaj; Billy R Martin
Journal:  J Nat Prod       Date:  2010-03-26       Impact factor: 4.050

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.